Participating Companies

Companies participating at China Showcase 2020.

 
USA

20/20 GeneSystems, Inc.

 
 
USA

3EBIOVENTURES

 
 
China

6 dimensions capital

 
 
USA

ABES Venture Partners

 
USA

Abilita Bio, Inc.

 
USA

Achelios Therapeutics

 
 
USA

Aegis Capital Corp.

 
 
Japan

Aflac Innovation Partners G.K.

 
Australia

Agilex Biolabs

 
 
Netherlands

Aglaia Oncology Funds

 
USA

ALEON PHARMA INTERNATIONAL

 
 
USA

Alteogen Inc.

 
 
USA

Angex Pharmaceutical Inc

 
 
China

AnHeart Therapeutics (Hangzhou) Co.

 
 
USA

Asahi Kasei

 
Japan

Asahi Kasei Pharma Corporation

 
 
Japan

Asajes Ventures

 
USA

Ascendia Pharmaceuticals

 
USA

ASDERA LLC

 
United Kingdom

AstraZeneca

 
 
USA

Atheneos Ventures, LLC

 
India

Aurigene Discovery Technologies Ltd

 
United Kingdom

Avacta Life Sciences

 
 
USA

Baidu Ventures

 
 
Hong Kong

Bain Capital

 
 
Denmark

Bioinnovation Institute

 
 
Switzerland

BioMedPartners AG

 
 
Australia

BioScience Managers Pty Ltd

 
 
USA

BioSense Global LLC

 
 
Spain

Biotechnology Business Institute

 
 
USA

BioValleyCHINA Ventures

 
Switzerland

BioVersys AG

 
 
USA

Boehringer Ingelheim

 
China

Boehringer Ingelheim International Trade (Shanghai) Co., Ltd.

 
 
China

BOHE Angel Fund

 
 
Belgium

Bone Therapeutics

 
 
USA

BryoLogyx Inc

 
 
USA

BVCF

 
USA

Capellla Therapeutics, Inc.

 
 
USA

Capgenic Advisors

 
 
Taiwan

Cathay Venture Inc.

 
USA

Cato Research Ltd

 
USA

Cello Health BioConsulting

 
China

Chengdu Baiyu Pharmaceutical Co

 
China

ChinaBio Group

 
 
USA

Class Bravo Ventures

 
China

CMS

 
USA

Content Carnivores, LLC

 
United Kingdom

Coulter Partners

 
 
USA

Cowin Venture

 
USA

Creatv MicroTech, Inc.

 
Netherlands

Cristal Therapeutics

 
 
USA

Crosswave Management

 
USA

Cryoport

 
 
United Kingdom

DeBere Capital Partners

 
 
China

Decheng Capital

 
 
USA

Delaware Innovation Space, Inc.

 
USA

DFA Consulting

 
 
USA

DFB Pharmaceuticals LLC

 
 
USA

DHVC

 
USA

Diapin Therapeutics

 
 
Brit.Virgin Is.

Discover Fund Management

 
Singapore

DotBio

 
 
Belgium

DROIA NV

 
USA

DrugCendR Inc.

 
 
USA

Easton Capital

 
USA

EBD

 
USA

EMD Serono

 
USA

EOC Pharma

 
Japan

e-Projection K.K.

 
United Kingdom

ERA Consulting UK lTD

 
 
Singapore

Esco Ventures X

 
 
China

FC Capital

 
 
USA

Fortunatus Capital

 
 
USA

G4S Capital

 
USA

Galenus Therapeutics Inc.

 
USA

Gene To Be

 
 
China

GF Venture Capital

 
 
China

GL Capital Group

 
 
USA

Global Alpha Ventures

 
Canada

Glysantis Inc.

 
 
USA

Good Health Capital NY

 
 
USA

Gore Range Capital

 
 
China

Gracell Biotechnologies

 
 
Canada

GreenSky Capital

 
 
USA

GSR VENTURES

 
 
China

GTJA Investment Group

 
 
India

Health Passion Fund

 
 
USA

Helix Ventures

 
China

Henlius Biotech, Inc.

 
 
Singapore

Heritas Capital Management

 
 
Germany

High-Tech Gruenderfonds

 
 
USA

Hongjing Capital

 
USA

Horizon Therapeutics

 
USA

HUYA Bioscience International LLC

 
USA

IACTA Pharmaceuticals, Inc.

 
 
USA

Iaso Ventures

 
South Korea

ImmuneMed, Inc.

 
 
USA

Inhalon Biopharma

 
 
United Kingdom

InHealth Ventures

 
 
Italy

Innogest Capital

 
Belgium

Janssen Pharma

 
 
USA

JDRF T1D Fund

 
 
USA

Jina Ventures Inc

 
USA

Jones Day

 
China

JS InnoPharm (Shanghai) Ltd

 
 
USA

Julz Co LLC

 
 
China

Kaitai Capital

 
Japan

Kaken Pharmaceutical Co Ltd

 
Canada

KisoJi Biotechnology

 
 
USA

LAM Capital

 
 
USA

Landmark Angels/Family Office

 
USA

Landos Biopharma

 
 
China

Laurel Venture Capital Ltd

 
 
USA

Leopold and Ruth Friedman Foundatio

 
 
USA

LG Technology Ventures

 
 
USA

Life Science Angels

 
Australia

Linear Clinical Research

 
China

Lingmed

 
United Kingdom

Lonza

 
 
Canada

Lumira Ventures

 
 
Denmark

Lundbeckfonden Emerge

 
 
USA

LYFE Capital

 
 
China

Lynx Capital

 
 
China

LYZZ CAPITAL ADVISORS

 
 
USA

MaDu, LLC

 
USA

MaveriX Oncology Inc

 
 
USA

Maxim Group, LLC

 
USA

Mekanistic Therapeutics, LLC

 
 
USA

Mesa Verde Venture Partners

 
 
USA

Mighty Capital

 
 
China

Milestone Capital

 
Singapore

Mirxes Pte Ltd

 
 
Japan

Mitsui & Co. Global Investment, Inc.

 
 
USA

Mitsui Global Investment

 
 
USA

Molekule Consulting

 
 
USA

Molex Ventures LLC

 
 
United Kingdom

Momentum Biotech

 
 
USA

Moore Venture Partners

 
 
China

Morningside Ventures

 
USA

MSQ Ventures

 
 
USA

NCL Technology Ventures

 
 
USA

NEA

 
 
USA

Nieuw Amsterdam Advisors

 
 
USA

Noble Life Science Partners

 
Hong Kong

Nomura International HK Ltd

 
 
USA

Northern Light Venture Capital

 
 
USA

Oceaniq Capital

 
 
USA

OrbiMed

 
 
USA

ORIX Growth Capital

 
United Kingdom

Owlstone Medical Ltd

 
United Kingdom

Oxford BioMedica PLC

 
 
Italy

Panakes Partners

 
USA

Panorama Medicine

 
 
USA

Pappas Capital

 
USA

Philips Healthcare

 
France

Pierre Fabre Medicament

 
United Kingdom

Pneumagen Ltd

 
Switzerland

Preci Health SA.

 
USA

Preclinical GPS

 
 
Hong Kong

Qiming Venture Partners

 
 
China

Qiming Weichuang Venture Capital Management (Shanghai) Co. Ltd.

 
 
China

Quan Capital

 
 
USA

RedCrow Capital

 
 
USA

Reed-Ventures

 
USA

Renexes LLC

 
USA

Reuters News

 
USA

reVision Therapeutics, Inc.

 
USA

Rockwell Medical

 
 
USA

Ryan Witt

 
South Korea

Samsung Biologics

 
 
Hong Kong

Sanford C. Bernstein

 
Australia

Scientia Clinical Research

 
 
South Korea

Seven Tree Equity Partners

 
China

Shanghai LIDE Biotech Co Ltd

 
 
USA

Shaw Strategic Capital

 
 
China

Shenzhen GTJA Investment Group

 
USA

Shuttle Pharmaceuticals

 
United Kingdom

Silence Therapeutics plc

 
 
USA

Silk Road Financial Holding Group

 
USA

Smooth Drug Development

 
 
South Korea

SM-Sino Technology Investment

 
Czech Republic

Sotio a.s.

 
 
China

Starquest Capital

 
USA

STAT

 
 
USA

Stifel

 
USA

Stingray Therapeutics, Inc.

 
Japan

Sumitomo Dainippon Pharma

 
USA

Syneos Health

 
 
Italy

Tandem Ventures

 
 
USA

Tech.Bio Fund

 
 
USA

TechAcq Ventures

 
USA

Thrive Bioscience, Inc.

 
China

Timmune Biotech Led

 
 
USA

TransPacific Venture Capital Partners

 
 
USA

Tribeca Companies

 
 
USA

Two Sigma Ventures

 
USA

Vasomune Therapeutics, Inc.

 
 
Switzerland

Vaximm AG

 
USA

Verum Diagnostics Inc

 
 
China

Viva BioInnovator

 
 
USA

West Global Capital Limited

 
 
USA

WI Harper Group

 
USA

WideTrial

 
 
Canada

WinnerMax Capital

 
United Kingdom

Worldwide Clinical Trials

 
 
Christmas Islnd

Wuxi Biologics

 
 
Germany

www.aescuvest.eu

 
USA

Xconomy Inc

 
 
Malaysia

Xeraya Capital

 
 
USA

Yangtze Investment BVI

 
USA

YourChoice Therapeutics

 
 
USA

Yuhang Capital

 
 
USA

Zacks Small Cap Research

 
 
USA

ZGC Innovation Fund

 
Israel

Zmed Laser